Browse Heartland
-
- Health Care News
- Health Care
Trump EO to Bring U.S. Drug Prices in Line with Other Countries’
Publication -President Donald Trump issued an executive order (EO) aimed at drastically reducing the cost of prescription drugs for Americans by tying their prices to those in other nations. A February 2024 Rand report found U.S. drug prices average 2.78 times higher than those in an index of 33 other nations. The disparity is even greater […] -
Federal Court Strikes Down Trump Rule on Drug Prices in TV Ads
Opinion -The Trump administration’s plans to promote transparency in drug pricing suffered a significant, if not entirely unexpected, -
House Bills Propose Medicare to Negotiate Prescription Drug Prices
Opinion -Congressional Democrats and one Republican are proposing a package of bills they say will lower drug prices, including a measure giving Medicare more power to set drug prices. -
Trump Working to Reduce Drug Prices
Opinion -The United States has been very nearly subsidizing the global drug pharmaceutical trade while other nations pat themselves on the back for keeping prices low. -
Trump Administration To Target Prescription Drug Prices
Opinion -The Trump administration has recently released a plan to target the price of prescription drugs by implementing free-market solutions to help bring down the cost of health care. -
Poll: Voters Want Congress to Act on Prescription Drug Prices
Opinion -A large majority of registered voters say Congress should prioritize reducing prescription drug prices, according to a poll commissioned by an independent national patient organization. -
Current Proposals to Reduce Drug Prices Are Hit-and-Miss
Opinion -Policy Advisor Devon Herrick parses free-market policies from unsound proposals. -
Analysis: Who Is Responsible for High Drug Prices?
Opinion -Deregulation would increase competition and make drugs cheaper, according to Devon Herrick at the National Center for Policy Analysis -
Research & Commentary: Reimporting Drugs Will Not Bring Down Drug Prices
Publication -Research and Commentaries -In this Research & Commentary, Matthew Glans examines drug reimportation and why it is not the answer to high prescription drug prices. -
The Mystery of Prescription Drug Prices
Opinion -How can it be that the same exact prescription drug can have such markedly different prices?Recently, my patients with commercial insurance were paying $15 out of pocket per vial for analogue rapid-acting insulin. -
All I Want for Christmas Is Lower Drug Prices
Opinion -Consumer Power Report #486 One of the most significant struggles facing millions of Americans today is the growing cost of pharmaceuticals. According to U.S. News and World Report, U.S. -
Drug Prices Rise As Companies Anticipate New Restrictions
Opinion -As Congress continues to debate sweeping health care legislation, reports indicate the threat of greater regulation is already hiking costs as drug companies are reportedly raising prices in anticipation of lost income due to expanded taxes and fines, -
Market Factors Are Best Regulator of Drug Prices
Opinion -A timely question, given the new Medicare drug benefit launched last year, is how increasing insurance coverage is likely to affect innovation in the pharmaceutical industry. -
DC City Council to Regulate Drug Prices
Opinion -On May 3, the District of Columbia City Council unanimously passed a measure that would make it an illegal trade practice to charge too much for prescription drugs. -
Comparison Shopping Can Reduce Prescription Drug Prices
Opinion -High prescription drug prices and what to do about them were high on the campaign agendas of candidates across the country, and those issues will likely find their way into legislative proposals at the state and federal level next year. -
Solution to High Prescription Drug Prices
Opinion -CHICAGO: High prescription drug prices and what to do about them have become major issues in state and federal political races in Missouri. But advocates of having the government “do something” to lower prices may be overlooking a far simpler solution. -
Wrong Prescription for High Drug Prices
Opinion -One of the Clinton-Gore administration’s final acts before leaving office was to launch a campaign to demonize the nation’s pharmaceutical industry. -
Medicaid Waivers: Wrong Cure for High Drug Prices
Opinion -The Health Care Financing Administration (the agency that runs Medicare and Medicaid) can waive some federal requirements for Medicaid eligibility to allow states to experiment with new ways of delivering health care to the poor. -
New Rule Requires Drug Companies to State Prices in Ads
Opinion -America’s $450 billion-a-year drug industry is about to get a new wrinkle as a rule finalized in May by the U.S. Department of Health and Human Services (HHS) requires all pharmaceutical companies to include the list prices of their drugs and biological p -
Drug Manufacturers Raise Prices
Opinion -Several major drug manufacturers raised list prices for many drugs in July, two months after President Donald Trump offered his blueprint to lower prescription medication costs. -
President Trump Can End Drug Shortages, Reduce Prices By Promoting Competition
Opinion -The kickback scheme created by the "safe harbor" is directly responsible for drug shortages and price hikes because it has destroyed the economic incentive to produce many critical life-saving medicines. -
Wal-Mart Drug Discounts Increase Competition and Lower Prices
Opinion -In September 2006, Wal-Mart rolled out a plan to sell 291 generic prescription medications at $4 for a 30-day supply at selected pharmacies in Florida. At the same time, it announced plans to expand the program to 14 additional states. -
Need, Not Greed, Is What’s Causing High Prices for Prescription Drugs
Opinion -Editor's note: In part 1 of this article (Health Care News, December 2004), the author explored how the pharmaceutical firm AstraZeneca developed a heartburn drug, Nexium, when the patent on the drug company's other heartburn drug, Prilosec, was -
Need, Not Greed, Is What’s Causing High Prices for Prescription Drugs
Opinion -Ten years ago, the multinational pharmaceutical company AstraZeneca launched what was known inside the company as the Shark Fin Project.
What's New
Heartland Newsletters
The Heartland Institute offers free email subscriptions to all of its newsletters and monthly public policy newspapers.